Qiagen Gets $600K From US DoD to Ramp up COVID-19 Test Kit, Reagent Manufacturing

URLhttps://www.genomeweb.com/molecular-diagnostics/qi
SourceGenomeweb
Date Published08/24/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Qiagen
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2022
Domestically, the work will be done:In-house
Capital investment ($):0.6
Country(ies) from which reshored:Germany
City reshored to:Beverly
State(s) reshored to:MA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredcovid test kits
What domestic positive factors made reshoring more attractive?Government Incentives
Government Incentive dollar amount:$600,000
Find Reshoring Articles